TY  - JOUR
AU  - Piñol Cancer, Marina
AU  - Fernández Méndez, Laura
AU  - Carrillo Romero, Juliana
AU  - Urkola Arsuaga, Ainhize
AU  - Azkargorta, Mikel
AU  - Elortza, Félix
AU  - Goñi de Cerio, Felipe
AU  - García Mouton, Cristina
AU  - Miranda-Pérez de Alejo, Claudia
AU  - Ismalaj, Ermal
AU  - Cañadas Benito, Olga
AU  - Pérez Gil, Jesús
AU  - Ruiz-Cabello Osuna, Jesús
AU  - Carregal Romero, Susana
PY  - 2025
DO  - 10.1016/j.jconrel.2025.114134
SN  - 0168-3659
UR  - https://hdl.handle.net/20.500.14352/124382
T2  - Journal of Controlled Release
AB  - PEGylation is commonly used to improve the pharmacokinetics and efficacy of intravenously administered drug nanocarriers; however its impact on pulmonary drug delivery remains unclear. While previous studies have focused on its role in crossing the...
LA  - eng
M2  - 1
PB  - Elsevier
KW  - PEGylation
KW  - Lipid nanoparticles
KW  - Mucus interaction
KW  - Lung surfactant corona
KW  - Pulmonary fibrosis
KW  - Pirfenidone
TI  - The role of PEGylation in the pulmonary delivery of antifibrotic liposomal therapies
TY  - journal article
VL  - 386
ER  -